Literature DB >> 1168475

Uptake and binding of vincristine by murine leukemia cells.

W A Bleyer, S A Frisby, V T Oliverio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1168475     DOI： 10.1016/0006-2952(75)90185-9

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  14 in total

1.  Vincristine potentiates cytochalasin B-induced DNA fragmentation in vitro.

Authors:  M A Kolber; P Hill
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Improved tolerance of vincristine by glutamic acid. A preliminary report.

Authors:  D V Jackson; E K Pope; L D Case; H B Wells; D R White; M R Cooper; R D Caldwell; W R Black; H B Muss; J M Cruz
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

3.  Role of the OATP Transporter Family and a Benzbromarone-SensitiveEfflux Transporter in the Hepatocellular Disposition of Vincristine.

Authors:  Johan Nicolaï; Louise Thevelin; Qi Bing; Bruno Stieger; Hugues Chanteux; Patrick Augustijns; Pieter Annaert
Journal:  Pharm Res       Date:  2017-08-21       Impact factor: 4.200

4.  Membrane transport changes in an adriamycin-resistant murine leukemia cell line and in its sensitive parental cell line.

Authors:  R Bose; H Y Lam
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

Review 5.  Antineoplastic drugs: clinical pharmacology and therapeutic use.

Authors:  R A Bender; L A Zwelling; J H Doroshow; G Y Locker; K R Hande; D S Murinson; M Cohen; C E Myers; B A Chabner
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

6.  Relationship between the cellular accumulation and the cytotoxicity of S12363, a new Vinca alkaloid derivative.

Authors:  A Pierré; V Pérez; S Léonce; J A Boutin; D Saint-Dizier; P Hautefaye; G Lavielle; G Atassi
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 7.  5-Fluorouracil containing combinations in murine tumor systems.

Authors:  T H Corbett; M C Bissery; P Mucci-LoRusso; L Polin
Journal:  Invest New Drugs       Date:  1989-04       Impact factor: 3.850

Review 8.  Preclinical and clinical pharmacology of vinca alkaloids.

Authors:  X J Zhou; R Rahmani
Journal:  Drugs       Date:  1992       Impact factor: 9.546

9.  Decreased retention of vinca alkaloids in chronic lymphatic leukemia cells from refractory patients.

Authors:  M Beksac; C Peterson; P Reizenstein
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

10.  Collateral sensitivity of a methotrexate-resistant L1210 cell line to the vinca alkaloids.

Authors:  D G Poppitt; A T McGown; B W Fox
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.